News · 26 weeks600%
2025-12-282026-06-21
Mix4690d
- Insider18(39%)
- SEC Filings13(28%)
- Other10(22%)
- Leadership3(7%)
- Earnings2(4%)
Latest news
25 items- PRWeight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight StudyNEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced that it is continuing its long-standing support of the American Heart Association by engaging members to enroll and participate in the Healthy Living BEYOND Weight™ Study. The American Heart Association’s Healthy Living BEYOND Weight Study is one of the most inclusive efforts to understand the lived experiences and long-term health outcomes of people living with obesity or those who are overweight. Weight Watchers offers a comprehensive care model that supports people throughout their weight health journey, including those u
- INSIDERSEC Form 4 filed by Director Hawks Carney4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 4 filed by Director Gavales Lisa A4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 4 filed by Director Thiltgen Heather4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 4 filed by Director Gove Sue4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 4 filed by Director Davis Eugene I4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 4 filed by Director Sjoqvist Nikolaj H4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- PRWeight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UKThe collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for weight-loss treatment, including access to CheqUp's clinical service in the UK, mirroring the integrated clinical model in the US. NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, and CheqUp, the UK's leading digital weight health platform, today announced a significant expansion of their partnership, bringing together best-in-class behavioural and clinical support for people on a weight management
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- SECSEC Form DEFA14A filed by WW International Inc.DEFA14A - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirectNEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) and its affiliated medical groups ("Weight Watchers"), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform, LillyDirect®. This news further reflects Weight Watchers' continued focus on expanding access to trusted, brand-name GLP-1 medications paired with comprehensive clinical and behavioral support, designed for real life. LillyDirect is enabling access to another independent care offering at a time when demand for GLP-1 medications continues to grow. Through LillyDirect, patients can connect with independent care options, pharmacy fulfill
- INSIDERCFO & Member, IOCE Dellafortuna Felicia bought $19,012 worth of shares (1,500 units at $12.68) (SEC Form 4)4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERDirector Davis Eugene I bought $295,798 worth of shares (21,648 units at $13.66) (SEC Form 4)4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERChief Ops Off. & Member, IOCE Volkmann Jonathan bought $15,120 worth of shares (1,500 units at $10.08), increasing direct ownership by 88% to 3,196 units (SEC Form 4)4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERDirector Sjoqvist Nikolaj H bought $95,500 worth of shares (10,000 units at $9.55), increasing direct ownership by 419% to 12,385 units (SEC Form 4)4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERDirector Hawks Carney bought $200,256 worth of shares (20,000 units at $10.01), increasing direct ownership by 64% to 51,442 units (SEC Form 4)4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- SECSEC Form DEFA14A filed by WW International Inc.DEFA14A - WW INTERNATIONAL, INC. (0000105319) (Filer)
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by WW International Inc.SCHEDULE 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
- SECSEC Form 10-Q filed by WW International Inc.10-Q - WW INTERNATIONAL, INC. (0000105319) (Filer)
- SECWW International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Announces First Quarter 2026 ResultsTotal End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32% year-over-year Reaffirms Full Year 2026 Financial Guidance Announces Fully Subscribed Debt Prepayment Solicitation as Part of Actions Expected to Reduce Debt by $42 Million NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced its results for the first quarter of fiscal 2026 ended March 31, 20261 in this Earnings Press Release and a Shareholder Letter issu
- PRWeight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk's now available Ozempic® pill (semaglutide) through its Med+ offering and affiliated medical groups. The addition will give members a once-daily GLP-1 option for adults living with type 2 diabetes, further expanding Weight Watchers' growing portfolio of oral GLP-1 treatments available through a clinically supported program designed to help members succeed. Novo Nordisk first introduced Ozempic® in the U.S. as an injectable GLP-1 for adults with type 2 diabetes, and the brand ha
- SECSEC Form DEF 14A filed by WW International Inc.DEF 14A - WW INTERNATIONAL, INC. (0000105319) (Filer)
- INSIDERAmendment: New insider Volkmann Jonathan claimed ownership of 1,696 shares (SEC Form 3)3/A - WW INTERNATIONAL, INC. (0000105319) (Issuer)
WW FAQ
6 questionsWhat does WW International Inc. do?
WW International, Inc. provides weight management products and services worldwide. The company operates in four segments: North America, Continental Europe, United Kingdom, and Other. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and Web-based products, including personal coaching and digital...Where does WW stock trade?
WW International Inc. (WW) is listed on NASDAQ.What sector and industry is WW in?
WW International Inc. operates in the Consumer Discretionary sector, Other Consumer Services industry.What are analysts saying about WW?
WW International Inc. has had 8 recent analyst actions on file. The most recent action was from CJS Securities: Market Perform on 2025-09-15.What companies are similar to WW?
Notable peers in the same industry include BAM (Brookfield Asset Management Inc), SE (Sea Limited), EDU (New Oriental Education & Technology Group Inc. Sponsored ADR r), SCI (Service Corporation International), IT (Gartner Inc.). Compare WW side-by-side with any of them on Quantisnow.How can I track WW on Quantisnow?
Quantisnow aggregates WW International Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow WW to receive live email and push alerts on every new disclosure.